About 3 Trademarks found that are owned by Goryo Chemical Inc.

In the statement, lines 2 thru 4, " EAREE Bldg. 5F, 35-100, Kita-8jo-Nishi 18-chome, Chuo-ku Japan" should be deleted, and EAREE Bldg. 5F, 35-100, Kita-8jo-Nishi 18-chome, Chuo-ku Sapporo-shi, Hokkaido Japan 060-0008 should be inserted.

Pharmaceutical preparations and substances for the diagnosis and treatment, and the prevention of breast, brain, colorectal and gastro-intestinal cancer; pharmaceutical preparations and substances used for detecting body fluids; pharmaceutical preparations and substances used for detecting pancreatic fluids; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cancer; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of digestive system disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of bone diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hyperlipidemia diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of gastrointestinal diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypoglycemia; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of sarcoma; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of immune system diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypertension; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of respiratory diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of skin disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of multiple sclerosis; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cardiovascular diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating central nervous system disorders; diagnostic biomarker reagents for medical purposes; veterinary diagnostic reagents; fluorescent diagnostic reagents for veterinary purposes; fluorescent diagnostic test reagents for veterinary purposes; diagnostic test reagents for medical purposes; fluorescent diagnostic test reagents for medical purposes; fluorescent diagnostic reagents for medical purposes; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; fluorescent medical diagnostic reagents; chemical reagents for veterinary purposes; fluorescent chemical reagents for veterinary purposes; chemical reagents for medical purposes; fluorescent chemical reagents for medical purposes; reagents for medical purposes; fluorescent reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and analysis samples for testing of body fluids; medical fluorescent diagnostic reagents and assays for testing of body fluids; medical fluorescent diagnostic reagents and analysis samples for testing of body fluids; medical clinical diagnostic reagents; fluorescent reagents for the clinical diagnosis; therapeutic drugs and agents, namely, agents for the treatment of malignant tumors

The mark consists of a five pointed star design formed by five blue diamonds.

In the statement, line 3, after Chuo-Ku, ", Sapporo-shi, Hokkaido" should be should be inserted, and in the statement, line 4, after Japan, "060-0008" should be inserted.

In the statement, lines 2 thru 4 should be deleted, and "EAREE Bldg. 5F, 35-100, Kita-8jo-Nishi 18-chome, Chuo-ku, Sapporo-shi, Hokkaido, Japan 060-0008" should be inserted.

Pharmaceutical preparations and substances for the diagnosis and treatment, and the prevention of breast, brain, colorectal and gastro-intestinal cancer; pharmaceutical preparations and substances used for detecting body fluids; pharmaceutical preparations and substances used for detecting pancreatic fluids; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cancer; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of digestive system disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of bone diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hyperlipidemia diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of gastrointestinal diseases; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypoglycemia; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of sarcoma; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of immune system diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of hypertension; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of respiratory diseases and disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of skin disorders; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of multiple sclerosis; pharmaceutical preparations and substances for the diagnosis and treatment, or the prevention of cardiovascular diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating central nervous system disorders; diagnostic biomarker reagents for medical purposes; veterinary diagnostic reagents; fluorescent diagnostic reagents for veterinary purposes; fluorescent diagnostic test reagents for veterinary purposes; diagnostic test reagents for medical purposes; fluorescent diagnostic test reagents for medical purposes; fluorescent diagnostic reagents for medical purposes; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; fluorescent tracer agent for medical diagnostics or veterinary purposes; chemical reagents for veterinary purposes; fluorescent chemical reagents for veterinary purposes; chemical reagents for medical purposes; fluorescent chemical reagents for medical purposes; reagents for medical purposes; fluorescent reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; medical diagnostic reagents and analysis samples for testing of body fluids; medical fluorescent diagnostic reagents and assays for testing of body fluids; medical fluorescent diagnostic reagents and analysis samples for testing of body fluids; medical clinical diagnostic reagents; fluorescent reagents for the clinical diagnosis; therapeutic drugs and agents, namely, agents for the treatment of malignant tumors